T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins-Reference-Cited by-同舟云学术

T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins

Published:2013-11-20 Issue:3 Volume:134 Page:563-574
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Salerno Elise P.¹,Olson Walter C.¹,McSkimming Chantel¹,Shea Sofia¹²,Slingluff Craig L.¹

Affiliation:

1. Division of Surgical Oncology, Department of Surgery; University of Virginia; Charlottesville VA

2. Department of Dermatology; University of Virginia; Charlottesville VA

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response;Mihm;Lab Invest,1996

2. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival;Bogunovic;Proc Natl Acad Sci USA,2009

3. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma;Erdag;Cancer Res,2012

4. Integrin function in T-Cell homing to lymphoid and nonlymphoid sites: getting there and staying there;DeNucci;Crit Rev Immunol,2009

5. Overview of integrin signaling in the immune system;Kinashi;Meth Mol Biol,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge;International Journal of Molecular Sciences;2024-08-31

2. Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion;Cancer Immunology, Immunotherapy;2024-05-02

3. Barriers to immune cell infiltration in tumors;Journal for ImmunoTherapy of Cancer;2023-04

4. CD103 and periplakin are potential biomarkers for response of metastatic melanoma to pembrolizumab;Melanoma Research;2022-09-28

5. An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes;Cancer Cell;2022-05